GPLD1

Revision as of 17:40, 4 September 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search


Glycosylphosphatidylinositol specific phospholipase D1
Identifiers
Symbols GPLD1 ; GPIPLD; GPIPLDM; MGC22590; PIGPLD; PIGPLD1
External IDs Template:OMIM5 Template:MGI HomoloGene1152
RNA expression pattern
More reference expression data
Orthologs
Template:GNF Ortholog box
Species Human Mouse
Entrez n/a n/a
Ensembl n/a n/a
UniProt n/a n/a
RefSeq (mRNA) n/a n/a
RefSeq (protein) n/a n/a
Location (UCSC) n/a n/a
PubMed search n/a n/a

Glycosylphosphatidylinositol specific phospholipase D1, also known as GPLD1, is a human gene.[1]

Many proteins are tethered to the extracellular face of eukaryotic plasma membranes by a glycosylphosphatidylinositol (GPI) anchor. The GPI-anchor is a glycolipid found on many blood cells. The protein encoded by this gene is a GPI degrading enzyme. Glycosylphosphatidylinositol specific phospholipase D1 hydrolyzes the inositol phosphate linkage in proteins anchored by phosphatidylinositol glycans, thereby releasing the attached protein from the plasma membrane.[1]

References

  1. 1.0 1.1 "Entrez Gene: GPLD1 glycosylphosphatidylinositol specific phospholipase D1".

Further reading

  • Hoener MC, Brodbeck U (1992). "Phosphatidylinositol-glycan-specific phospholipase D is an amphiphilic glycoprotein that in serum is associated with high-density lipoproteins". Eur. J. Biochem. 206 (3): 747–57. PMID 1606959.
  • Scallon BJ, Fung WJ, Tsang TC; et al. (1991). "Primary structure and functional activity of a phosphatidylinositol-glycan-specific phospholipase D.". Science. 252 (5004): 446–8. PMID 2017684.
  • Metz CN, Brunner G, Choi-Muira NH; et al. (1994). "Release of GPI-anchored membrane proteins by a cell-associated GPI-specific phospholipase D.". EMBO J. 13 (7): 1741–51. PMID 7512501.
  • Jinnai H, Nakamura S (2000). "Characterization of phospholipase D activation by GM2 activator in a cell-free system". The Kobe journal of medical sciences. 45 (3–4): 181–90. PMID 10752311.
  • Schofield JN, Rademacher TW (2000). "Structure and expression of the human glycosylphosphatidylinositol phospholipase D1 (GPLD1) gene". Biochim. Biophys. Acta. 1494 (1–2): 189–94. PMID 11072085.
  • Deeg MA, Bierman EL, Cheung MC (2001). "GPI-specific phospholipase D associates with an apoA-I- and apoA-IV-containing complex". J. Lipid Res. 42 (3): 442–51. PMID 11254757.
  • Tang J, Li W (2002). "[Methodological study on the assay of glycosylphosphatidylinositol-specific phospholipase D activity in serum]". Hunan Yi Ke Da Xue Xue Bao. 24 (2): 119–22. PMID 11938765.
  • Slomiany A, Nishikawa H, Slomiany BL (2002). "Screening and modulation of extracellular signals by mucous barrier. Serum glycosylphosphatidylinositol phospholipase D (GPI-PLD) releases protective mucous barrier from oral mucosa". J. Physiol. Pharmacol. 53 (1): 21–38. PMID 11939716.
  • Jaworek J, Bonio J, Leja-Szpa A; et al. (2002). "Sensory nerves in central and peripheral control of pancreatic integrity by leptin and melatonin". J. Physiol. Pharmacol. 53 (1): 51–74. PMID 11939719.
  • Deeg MA, Bowen RF (2002). "Phosphorylation decreases trypsin activation and apolipoprotein al binding to glycosylphosphatidylinositol-specific phospholipase D.". Biochem. Cell Biol. 80 (2): 253–60. PMID 11989719.
  • Xiaotong H, Hannocks MJ, Hampson I, Brunner G (2002). "GPI-specific phospholipase D mRNA expression in tumor cells of different malignancy". Clin. Exp. Metastasis. 19 (4): 291–9. PMID 12090469.
  • Magnusson P, Sharp CA, Farley JR (2003). "Different distributions of human bone alkaline phosphatase isoforms in serum and bone tissue extracts". Clin. Chim. Acta. 325 (1–2): 59–70. PMID 12367767.
  • Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.
  • Tang JH, Gu SL, Zhang XJ (2003). "[Preliminary study of the gene structure of human glycosylphosphatidylinositol specific phospholipase D]". Hunan Yi Ke Da Xue Xue Bao. 26 (2): 95–7. PMID 12536633.
  • Mungall AJ, Palmer SA, Sims SK; et al. (2003). "The DNA sequence and analysis of human chromosome 6". Nature. 425 (6960): 805–11. doi:10.1038/nature02055. PMID 14574404.
  • Kurtz TA, Fineberg NS, Considine RV, Deeg MA (2004). "Insulin resistance is associated with increased serum levels of glycosylphosphatidylinositol-specific phospholipase D.". Metab. Clin. Exp. 53 (2): 138–9. PMID 14767861.
  • Gerhard DS, Wagner L, Feingold EA; et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334.
  • Lugli EB, Pouliot M, Portela Mdel P; et al. (2005). "Characterization of primate trypanosome lytic factors". Mol. Biochem. Parasitol. 138 (1): 9–20. doi:10.1016/j.molbiopara.2004.07.004. PMID 15500911.
  • Everett PB, Senogles SE (2005). "D3 dopamine receptor activates phospholipase D through a pertussis toxin-insensitive pathway". Neurosci. Lett. 371 (1): 34–9. doi:10.1016/j.neulet.2004.08.033. PMID 15500962.
  • Mead KI, Zheng Y, Manzotti CN; et al. (2005). "Exocytosis of CTLA-4 is dependent on phospholipase D and ADP ribosylation factor-1 and stimulated during activation of regulatory T cells". J. Immunol. 174 (8): 4803–11. PMID 15814706.

Template:WikiDoc Sources